ÂÜÀòÂÒÂ×

Adam Wieschhaus is a Director at Northpond Ventures and leads the firm’s work in life science R&D solutions, molecular diagnostics, and environmental sciences. Previously, Adam was a Vice President at Cowen and Company, where he covered the life science tools and diagnostics space for six years. Prior to Cowen, he conducted his postdoctoral studies at Tufts Medical School, where he developed and refined drug candidates across several therapeutic areas. He holds a Ph.D. from the University of Illinois College of Medicine, a B.S. in biochemistry and molecular biology from the University of Georgia, and is a CFA charter holder.